VRTX- Vertex Pharmaceuticals Incorporated

Name: Vertex Pharmaceuticals Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 60 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kewalramani Reshma	133.5K	$60.29M	-
COO	Arbuckle Stuart A	63.4K	$28.62M	-
VP	Wagner Charles F Jr	51.1K	$23.07M	-
VP	Tatsis Ourania	42.3K	$19.10M	-
Other	Leiden Jeffrey M	24.0K	$10.85M	-

Activity

Buys and sells only

Transactions

10 filings · page 30

Date	Insider	Role	Type	Shares	Price	Value	Chg%
May 6, 2020	Kewalramani Reshma55	CEO &President	Sale+OE	2,074	$272.85	$565,882.14	-1.5%
May 6, 2020	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sale+OE	1,222	$272.64	$333,164.58	-0.9%
May 6, 2020	Tatsis Ourania48	EVP, Chief Regulatory Officer	Sale+OE	966	$272.70	$263,431.17	-1.2%
May 6, 2020	Sachdev Amit	EVP, Chief Patient Officer	Sale+OE	669	$275.28	$184,162.32	-1.9%
May 5, 2020	Leiden Jeffrey M47	Executive Chairman	Sale+OE	94,372	$269.94	$25,475,036.61	-10.4%
May 5, 2020	Sachdev Amit	EVP, Chief Patient Officer	Sale+OE	57,108	$264.09	$15,081,411.55	-7.7%
May 4, 2020	Altshuler David48	EVP, Global Research And CSO	Sale+OE	2,330	$260.86	$607,803.01	-1.6%
May 4, 2020	Silva Paul M	SVP &Controller	Sale+OE	809	$260.87	$211,047.75	-1.1%
May 4, 2020	Arbuckle Stuart A	EVP, Chief Commercial Officer	Sale+OE	1,553	$260.76	$404,956.57	-0.9%
May 4, 2020	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sale+OE	2,330	$260.87	$607,827.29	-1.7%

← PrevPage 30Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC